# Legend Biotech Corporation (LEGN) stock price

URL: https://funkfolio.com/stock/LEGN

> Legend Biotech Corporation (LEGN) trades at $16.12, is worth $3.13B and scores 51/100. Valuation, financials and signals.

---

## Legend Biotech Corporation (LEGN)

Legend Biotech Corporation (LEGN) is a healthcare company (biotechnology) based in the United States. The share price is $16.12, up 0.78% on the day, which values the company at $3.13B. Price as of 17 Nov 2026, 20:26 UTC, from Yahoo Finance.

### Key facts

- **Share price:** $16.12 +0.78% today
- **Market value:** $3.13B
- **Forward P/E:** 30.5×
- **Funk Score:** 51/100
- **Against its own history:** Well below its usual price usual price $84.38
- **200-week average:** $42.13 62% below
- **Sector:** Healthcare

Figures as of 17 Nov 2026, 20:26 UTC. Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

### Legend Biotech Corporation in more detail

LEGN trades at 30.5× next year's expected earnings, 2.3× sales. Measured against its own history, the price is 81% below what its usual multiples would imply ($84.38) — well below its usual price. It sits 62% below its 200-week average of $42.13.

Its Funk Score is 51 out of 100 (financial strength 3.4, profitability 2.0, growth 10.0, value 5.0, each out of 10).

In its favour: Operating margin is expanding; More cash than debt. Worth checking: Altman Z in the distress zone; Weak Piotroski score.

1 of the superinvestors tracked here hold LEGN, including Zhang Lei (20.8% of the portfolio).

### Superinvestors holding LEGN

1 of the investors tracked here report a position in their latest 13F filing.

- [Zhang Lei HHLR Advisors (Hillhouse)](https://funkfolio.com/gurus/hillhouse) 20.8% of portfolio · $172.8M · Q2 2026

### Health Care companies of similar size

- [Merit Medical Systems MMSI](https://funkfolio.com/stock/MMSI)
- [Edgewise Therapeutics EWTX](https://funkfolio.com/stock/EWTX)
- [LivaNova LIVN](https://funkfolio.com/stock/LIVN)
- [Ionis Pharmaceuticals IONS](https://funkfolio.com/stock/IONS)
- [Dianthus Therapeutics DNTH](https://funkfolio.com/stock/DNTH)
- [MiniMed Group MMED](https://funkfolio.com/stock/MMED)
- [Adaptive Biotechnologies ADPT](https://funkfolio.com/stock/ADPT)
- [Heartflow HTFL](https://funkfolio.com/stock/HTFL)
- [CRISPR Therapeutics CRSP](https://funkfolio.com/stock/CRSP)
- [Travere Therapeutics TVTX](https://funkfolio.com/stock/TVTX)
- [Option Care Health OPCH](https://funkfolio.com/stock/OPCH)
- [Definium Therapeutics DFTX](https://funkfolio.com/stock/DFTX)

Side by side: [LEGN vs DFTX (Legend Biotech Corporation vs Definium Therapeutics)](https://funkfolio.com/compare/dftx-vs-legn) [LEGN vs OPCH (Legend Biotech Corporation vs Option Care Health)](https://funkfolio.com/compare/legn-vs-opch) [LEGN vs TVTX (Legend Biotech Corporation vs Travere Therapeutics)](https://funkfolio.com/compare/legn-vs-tvtx) [LEGN vs CRSP (Legend Biotech Corporation vs CRISPR Therapeutics)](https://funkfolio.com/compare/crsp-vs-legn) [LEGN vs HTFL (Legend Biotech Corporation vs Heartflow)](https://funkfolio.com/compare/htfl-vs-legn)

[All health care companies by market value](https://funkfolio.com/companies/sector/health-care) [Largest companies in the United States](https://funkfolio.com/companies/country/united-states) [All stocks A–Z](https://funkfolio.com/stocks)

### Legend Biotech Corporation (LEGN): questions and answers

**What is Legend Biotech Corporation's market cap?**

Legend Biotech Corporation is valued at $3.13B at a share price of $16.12.

**Is LEGN overvalued or undervalued?**

Against its own history, LEGN is well below its usual price: the price is 81% below the $84.38 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

**Is LEGN above its 200-week moving average?**

No. LEGN is 61.7% below its 200-week average of $42.13. Long-term investors watch that line because strong companies rarely trade below it for long.

**How fast is Legend Biotech Corporation growing?**

Over the last three fiscal years Legend Biotech Corporation's revenue grew 106.4% a year.

**Does LEGN pay a dividend?**

Legend Biotech Corporation does not currently pay a regular dividend.

**Which famous investors own LEGN?**

In their latest quarterly filings, Zhang Lei (20.8% of the portfolio) hold LEGN. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

### Learn to read these numbers

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.

### Cite this page

Funkfolio, “Legend Biotech Corporation (LEGN) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/LEGN

Underlying data: Yahoo Finance; company filings with the SEC.
